| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Resource name | Masks and Respirators | Post Discharge Care | Evidence Care Clinical Pathways Rapid Assessment | Evidence Care Acute MI | McMaster Covid Portal | Covid QTC Mayo | High Risk Viral Outbreak Diseases | American Society of Clinical OncologyCOVID-19 Patient Care Information | Interim Guidance for Life Support for COVID-19 | Pregnant and worried about the new coronavirus? | ClinicalTrials.gov | Sages N95 Mask Reuse | Nebraska Med Covid-19 PPE Guidance | Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers | Stayhome app | Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy | NHS Coronavirus Portal | Ethics Resources on the Coronavirus | Daily tracking: incidence, new deaths worldwide, recoveries (as reported) | 3M Worker Safety and Health Product overview | Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19) | Johns Hopkins Patient Stories + | United Nations Resources | BMJ Best Practices-COVID 19 (WHO primary ref) | UK Research and Innovation Organization: Research Questions for COVID 19 | Interoperability for COVID-19 Pandemic | Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT | Using social and behavioural science to support COVID-19 pandemic response | The role of biomarkers in diagnosis of COVID-19 – A systematic review | ||||||||||
2 | URL | https://covid-acts.ahrq.gov/display/COV/COVID-19%3A+Masks+and+Respirators+for+Health+Care+Providers | https://covid-acts.ahrq.gov/display/COV/COVID-19%3A+Post-Discharge+Care | https://covid19.evidence.care/dashboard/covid/pathway/-1665511894/1045412905 | https://www.mcmasterforum.org/find-evidence/covid-19-evidence | https://www.covidqtc.com | https://intermountainhealthcare.org/covid19-coronavirus-for-healthcare-professionals/inpatient-management/ | https://www.asco.org/asco-coronavirus-information/care-individuals-cancer-during-covid-19 | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.047463 | https://www.health.harvard.edu/blog/pregnant-and-worried-about-the-new-coronavirus-2020031619212 | https://clinicaltrials.gov/ | https://www.sages.org/n-95-re-use-instructions/ | https://www.nebraskamed.com/sites/default/files/documents/covid-19/COVID-Extended-Use-Reuse-of-PPE-and-N95.pdf?date03212020 | https://jamanetwork.com/journals/jamacardiology/fullarticle/2764299 | https://uwcirg.github.io/stayhomelanding/ | https://www.ucsf.edu/news/2020/04/417276/testing-tests-covid-19-antibody-assays-scrutinized-accuracy-ucsf-uc-berkeley | https://www.nhs.uk/conditions/coronavirus-covid-19/ | https://www.thehastingscenter.org/ethics-resources-on-the-coronavirus/ | http://worldometers.info/coronavirus | https://www.3m.com/3M/en_US/worker-health-safety-us/covid19/ | https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html | https://www.hopkinsmedicine.org/coronavirus/patient-stories/ | https://www.un.org/en/coronavirus/reference-documents-administrators-and-managers | https://bestpractice.bmj.com/topics/en-us/3000168/references | https://www.ukri.org/files/research-questions-for-covid-19/ | https://www.healthit.gov/isa/covid-19 | https://pubs.rsna.org/doi/full/10.1148/radiol.2020200905 | https://www.nature.com/articles/s41562-020-0884-z | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219356/ | |||||||||||
3 | Identified persona or role identifying the principal interest of the consumer of the Placemat. Intended to charactize the nature of the interest in the work | Intended Audience | ||||||||||||||||||||||||||||||||||||||
4 | Personas | |||||||||||||||||||||||||||||||||||||||
5 | Patient | X | x | X | X | X | X | x | x | x | x | x | ||||||||||||||||||||||||||||
6 | healthcare providers interacting directly with patients | Direct Care | X | X | X | X | X | X | x | x | x | X | X | X | X | X | x | x | x | x | x | x | x | x | ||||||||||||||||
7 | Administration | X | X | X | x | x | x | x | x | |||||||||||||||||||||||||||||||
8 | Research | X | x | X | ?x | x | x | x | x | x | x | x | x | |||||||||||||||||||||||||||
9 | Public Health | X | X | ?x | x | x | x | x | x | |||||||||||||||||||||||||||||||
10 | Journalists | |||||||||||||||||||||||||||||||||||||||
11 | Businesses | |||||||||||||||||||||||||||||||||||||||
12 | Location/environment of care. Capabilities and staff may vary among settings | Care Setting | NA | all? | ||||||||||||||||||||||||||||||||||||
13 | Home | x | x | X | x | x | x | x | ||||||||||||||||||||||||||||||||
14 | Telemedicine | x | x | x | x | |||||||||||||||||||||||||||||||||||
15 | Ambulatory | X | X | x | X | X | X | x | x | x | x | x | ||||||||||||||||||||||||||||
16 | Acute Care | X | X | x | x | x | X | X | X | x | x | x | x | x | x | |||||||||||||||||||||||||
17 | ED | X | X | x | x | x | ||||||||||||||||||||||||||||||||||
18 | Acute Care Ward | X | x | x | x | |||||||||||||||||||||||||||||||||||
19 | OR | x | x | |||||||||||||||||||||||||||||||||||||
20 | ICU | x | x | x | ||||||||||||||||||||||||||||||||||||
21 | Special Labs | Radiology | x | |||||||||||||||||||||||||||||||||||||
22 | Unspecified | |||||||||||||||||||||||||||||||||||||||
23 | Cath Lab | X | ||||||||||||||||||||||||||||||||||||||
24 | Discharge and Follow up | Post Acute Care | X | NA | x | x | ||||||||||||||||||||||||||||||||||
25 | Long Term Care | NA | x | x | ||||||||||||||||||||||||||||||||||||
26 | ||||||||||||||||||||||||||||||||||||||||
27 | Phase of care cycle relevent to the knowledge asset. For example, Prevention, Screening, Diagnosis, etc | Care Process | XXX | |||||||||||||||||||||||||||||||||||||
28 | Prevention | X | X | x | x | x | X | X | X | X | x | x | x | x | x | x | x | |||||||||||||||||||||||
29 | Screening | X | x | X | x | x | x | x | x | x | x | |||||||||||||||||||||||||||||
30 | Diagnosis | X | x | X | x | x | x | x | x | x | x | x | x | |||||||||||||||||||||||||||
31 | Treatment | X | x | X | x | X | x | x | x | x | x | x | ||||||||||||||||||||||||||||
32 | Procedures | x | x | |||||||||||||||||||||||||||||||||||||
33 | Medication | x | x | |||||||||||||||||||||||||||||||||||||
34 | Follow up | X | X | x | x | x | ||||||||||||||||||||||||||||||||||
35 | Public Health Reporting | X | x | x | x | |||||||||||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||||||||||||||||
38 | Primary topic(s) of interest address by the knowledge asset. | Subject | ||||||||||||||||||||||||||||||||||||||
39 | Care Management | X | X | X | X | x | x | X | x | x | x | x | x | x | ||||||||||||||||||||||||||
40 | Infection Control | X | X | x | x | X | X | x | x | x | x | x | x | |||||||||||||||||||||||||||
41 | Clinical Features and Diagnosis | X | X | X | x | x | x | x | x | x | ||||||||||||||||||||||||||||||
42 | Telemedicine | x | x | |||||||||||||||||||||||||||||||||||||
43 | equipment and personnel | Resource Management | x | |||||||||||||||||||||||||||||||||||||
44 | Personal Protection | X | X | x | x | X | X | X | x | x | x | x | ||||||||||||||||||||||||||||
45 | the detailed coordination of a complex operation involving many people, facilities, or supplies. the detailed coordination of a complex operation involving many people, facilities, or supplies. Keywords might include State-wide supply chain, in hospital, etc) | Logistics | X | X | x | x | x | |||||||||||||||||||||||||||||||||
46 | Predictive models of surges; within health care system planning and prediction | Clinical Epidemiology | X | x | x | x | x | x | ||||||||||||||||||||||||||||||||
47 | Laboratory | x | x | x | x | |||||||||||||||||||||||||||||||||||
48 | Keywords might include Diabetes, asthma | Comorbidities | X | X | x | x | x | x | ||||||||||||||||||||||||||||||||
49 | Keywords might include children, pregnancy | Special Populations | X | X | x | x | x | x | x | |||||||||||||||||||||||||||||||
50 | Jurisdictional (eg county or state) organizations that administer public health | Public Health & Case Reporting | X | ? | x | x | x | x | ||||||||||||||||||||||||||||||||
51 | Treatment | x | x | x | x | x | x | |||||||||||||||||||||||||||||||||
52 | Ethics | X | x | x | ||||||||||||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||||||||||||||||
55 | Type of asset by format, communication approach, formalism, etc | Asset | ||||||||||||||||||||||||||||||||||||||
56 | Data Visualization | x | ||||||||||||||||||||||||||||||||||||||
57 | Dashboards | x | ||||||||||||||||||||||||||||||||||||||
58 | Maps | |||||||||||||||||||||||||||||||||||||||
59 | Data Collection | |||||||||||||||||||||||||||||||||||||||
60 | Datasets | x | x? | x | ||||||||||||||||||||||||||||||||||||
61 | Keyword - Outcomes, | Registries | ||||||||||||||||||||||||||||||||||||||
62 | Assertion or Manifestation of Clinical Knowledge (Intention is that these are single select, but multiples can be used in cases of ambiguity) | Knowledge Resource | ||||||||||||||||||||||||||||||||||||||
63 | Systematically developed statements to assist practitioners and patient decisions about appropriate health care for specific circumstances"., such as are often published by professional societies | Guidelines | X | X | X | X | x | x | x | x | X | X | x | x | ||||||||||||||||||||||||||
64 | For instance, alerts and reminders | CDS Rules | ||||||||||||||||||||||||||||||||||||||
65 | Procedural algorithms, flowcharts or process steps, BPM+ | Workflows | X | x | ||||||||||||||||||||||||||||||||||||
66 | Suggested best practices, such as may be found in consensus recommendations. | Recommendation | X | X | X | x | x | x | x | x | x | |||||||||||||||||||||||||||||
67 | Formal representation for the interaction of variables or factors. These can vary widely from a simple truth table to a complex predictive model. | Models | X | x | ||||||||||||||||||||||||||||||||||||
68 | Examples include Order Sets, Patient Instructions, Pre and Post Op checklist | Checklist | X | X | X | X | x | |||||||||||||||||||||||||||||||||
69 | Examples include Risk Calculators, Dosing Calculators, etc | Calculators | X | |||||||||||||||||||||||||||||||||||||
70 | Policy is a rule that is an obligation; Procedures are organizational accepted practice | Policy & Procedures | X | X | x | x | x | |||||||||||||||||||||||||||||||||
71 | Clinical trials are experiments or observations done in clinical research | Clinical Trial | X | |||||||||||||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||||||||||||||||
73 | Enumerated lists of covid-19 related content. Generally links to primary content. There is a wide disparity in the curation of these lists. | Directories / Lists | X | x | X | X | x | x | x | x | x | |||||||||||||||||||||||||||||
74 | Health Systems | X | x | x | x | |||||||||||||||||||||||||||||||||||
75 | Government / Jurisdictional | X | X | x | x | x | x | |||||||||||||||||||||||||||||||||
76 | Standards Organizations | x | ||||||||||||||||||||||||||||||||||||||
77 | Includes NGOs and societies | Professional Groups | X | x | x | x | ||||||||||||||||||||||||||||||||||
78 | Commercial Entities | x | ||||||||||||||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||||||||||||||||
80 | The organization(s) that are curating an asset, and the strength of their recommendation. A given asset may be curated by more than one source. Our objective in documenting curation is to faithfully represent what others have done in curation. Note that organizations may curate lists of their own assets. | Curation | https://www.worldometers.info/about/; (Volunteer international organization of professionals.) | |||||||||||||||||||||||||||||||||||||
81 | Curator | AHRQ | AHRQ | ACEP | ACEP/ACC | McMaster University/Cochrane | Mayo | Intermountain | American Society of Clinical Oncology | AAMC | Harvard Health Publishing | SAGES | Nebraska Medicine | JAMA Cardiology | University of Washington Clinical Informatics Research Group | UCSF/ Berkley | UK NHS | Hastings Center | Worldometer | 3M | JHU | UN/WHO | BMJ/WHO | UK Research and Innovation org | HealthIT.gov | RSNA Radiology Journal | Nature Human Behaviour journal, | Life Science Journal | ||||||||||||
82 | Curation Value | |||||||||||||||||||||||||||||||||||||||
83 | There is some form of express endorsement about the asset | Recommended | X | X | X | X | X | X | x | x | x | x | x | x | ||||||||||||||||||||||||||
84 | The asset is linked but not explicitly endorsed. | Referenced | X | X | ||||||||||||||||||||||||||||||||||||
85 | Unspecified | |||||||||||||||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||||||||||||||||
87 | Filter Criteria | |||||||||||||||||||||||||||||||||||||||
88 | These attributes are intended to be used as general filter criteria in a "query by example" style of filtering | |||||||||||||||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||||||||||||||||
90 | Resources that are aimed at defining data and terminology structures | Data Representation | ||||||||||||||||||||||||||||||||||||||
91 | Vocabularies / Codes / Value sets | x | ||||||||||||||||||||||||||||||||||||||
92 | FHIR | x? | ||||||||||||||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||||||||||||||||
94 | Resources that provide a computable means of retrieving data. | Data Access / APIs | ||||||||||||||||||||||||||||||||||||||
95 | Bulk / Batch | |||||||||||||||||||||||||||||||||||||||
96 | (list top several interface protocols in use) | |||||||||||||||||||||||||||||||||||||||
97 | FHIR | |||||||||||||||||||||||||||||||||||||||
98 | Transactional | x | ||||||||||||||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||||||||||||||||
100 |